Neil Herskowitz insider trades
Open-market stock purchases and sales by Neil Herskowitz, Director at Journey Medical Corp, from SEC Form 4 filings since Mar 3, 2010.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -83%.
Companies traded
- DERM Journey Medical Corp: other filings, last Jun 25, 2026
- MBIO Mustang BIO, Inc: 1 buy, 1 sale, last Dec 30, 2025
- CKPT Checkpoint Therapeutics, Inc: other filings, last May 30, 2025
- ATXI Avenue Therapeutics, Inc: 18 buys, 1 sale, last Dec 2, 2024
- CNLM CB Pharma Acquisition Corp: 1 sale, last May 20, 2016
- TGTX TG Therapeutics, Inc: 1 buy, last Jun 6, 2014
- TGTXD TG Therapeutics, Inc: other filings, last May 16, 2012
- MHAN Manhattan Pharmaceuticals Inc: other filings, last Mar 8, 2010